ALS News | ALS Therapy Development Institute

Your support fuels our research to #EndALS! Donate Now

ALS Research News

Tuesday, December 27, 2022

ALS TDI's 2022 Milestones

You Need Treatments. We Own the Problem. We Do the Research.

Monday, December 12, 2022

What Clinical Trials are Recruiting Right Now?

A list of phase 3 clinical trials recruiting in the United States as of December 2022.

Wednesday, November 30, 2022

What are Pharmacokinetic and Pharmacodynamic Studies?

For anyone who follows drug development closely, the terms pharmacodynamics (PD) and pharmacokinetic

From trial readouts to news from our lab, you can find all of the latest ALS research news here.

More ALS Research News

COVID-19 Updates

Thursday, June 10, 2021

ALS TDI Welcomes Back Tours to our New Lab

Tuesday, June 2, 2020

How ALS TDI is Moving Forward with Phase 1 Reopening of Lab

Friday, May 29, 2020

ALS TDI Researchers Keep Essential Animal Experiments Running in the Lab

More COVID-19 Updates

ALS TDI Community Blog

Monday, January 23, 2023

Tri-State Trek Debuts New, Improved Format and Location in 2023

This year’s ride will feature more options for riders of all abilities while keeping the same #TrekFamily spirit.

Tuesday, January 17, 2023

Your ALS Guide: A Hub for Answering Important Questions about Living with ALS

Your ALS Guide is a website offering a wealth of content about living with ALS, caregiving, adaptive technology, and more.

Friday, December 23, 2022

Racing for ALS Celebrates a Big 2022, and Bigger Things to Come in 2023

Racing for ALS added more races and new services in 2022, raising record funds for ALS research. In 2023 they’re looking to do even more.

Blog posts and commentary pieces from ALS TDI and community members with topics ranging from funding ALS research to how ALS impacts the lives of community members.

ALS TDI Press Releases

Wednesday, September 28, 2022

ALS Therapy Development Institute Announces Superior Rail & Iron Works, Inc. as First Title Sponsor of White Coat Affair Gala

Superior Rail & Iron Works, Inc. will be the first Title Sponsor of the White Coat Affair gala, being held on October 15, 2022, at the Boston Sheraton to raise funds for ALS research.

Tuesday, May 31, 2022

Eledon Announces Phase 2a Trial Results for Tegoprubart - a Drug Invented at ALS TDI

Tuesday, March 1, 2022

Tegoprubart: AT-1501’s New Name

AT-1501, a drug invented at the ALS Therapy Development Institute (ALS TDI) and being developed by Eledon Pharmaceuticals, has a new name: tegoprubart.

A complete list of press releases from the ALS Therapy Development Institute.

More ALS TDI Press Releases

Learn more about our team, what what we're working on in the lab, and our amazing community by following us on social media!

Media Contact

We'd love to share our story with you. Speak to our team about our unique approach to end ALS.

marketing@als.net | 617.441.7200

ALS News & Stories